Evidence map›Paper›PMID 33131360›Full record

ArticleJournal of dental research2021

Diagnostic Salivary Tests for SARS-CoV-2.

L Azzi, V Maurino, A Baj, M Dani, A d'Aiuto, M Fasano, M Lualdi, F Sessa, T Alberio

Open access · hybridAbstract read
In one paragraph

Article in Journal of dental research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Development of practical techniques for simultaneous detection and distinction of current and emerging SARS-CoV-2 variants.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. The aftermath of the COVID-19 pandemic on oral medicine practice.Oral surgery, oral medicine, oral pathology and oral radiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

L AzziUnit of Oral Medicine and Pathology, ASST dei Sette Laghi-Ospedale di Circolo e Fondazione Macchi, Department of Medicine and Surgery, University of Insubria, Varese, Italy.ORCID https://orcid.org/0000-0003-2532-7651
V MaurinoUnit of Oral Medicine and Pathology, ASST dei Sette Laghi-Ospedale di Circolo e Fondazione Macchi, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
A BajLaboratory of Clinical Microbiology, ASST dei Sette Laghi-Ospedale di Circolo e Fondazione Macchi, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
M DaniUnit of Oral Medicine and Pathology, ASST dei Sette Laghi-Ospedale di Circolo e Fondazione Macchi, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
A d'AiutoUnit of Oral Medicine and Pathology, ASST dei Sette Laghi-Ospedale di Circolo e Fondazione Macchi, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
M FasanoLaboratory of Biochemistry and Functional Proteomics, Department of Science and High Technology, Busto Arsizio (VA), Italy.
M LualdiLaboratory of Biochemistry and Functional Proteomics, Department of Science and High Technology, Busto Arsizio (VA), Italy.ORCID https://orcid.org/0000-0002-0704-3439
F SessaUnit of Pathology, ASST dei Sette Laghi-Ospedale di Circolo e Fondazione Macchi, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
T AlberioLaboratory of Biochemistry and Functional Proteomics, Department of Science and High Technology, Busto Arsizio (VA), Italy.
University of Insubria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection relies on the detection of viral RNA by real-time reverse transcription polymerase chain reaction (rRT-PCR) performed with respiratory specimens, especially nasopharyngeal swabs. However, this procedure requires specialized medical personnel, centralized laboratory facilities, and time to provide results (from several hours up to 1 d). In addition, there is a non-negligible risk of viral transmission for the operator who performs the procedure. For these reasons, several studies have suggested the use of other body fluids, including saliva, for the detection of SARS-CoV-2. The use of saliva as a diagnostic specimen has numerous advantages: it is easily self-collected by the patient with almost no discomfort, it does not require specialized health care personnel for its management, and it reduces the risks for the operator. In the past few months, several scientific papers, media, and companies have announced the development of new salivary tests to detect SARS-CoV-2 infection. Posterior oropharyngeal saliva should be distinguished from oral saliva, since the former is a part of respiratory secretions, while the latter is produced by the salivary glands, which are outside the respiratory tract. Saliva can be analyzed through standard (rRT-PCR) or rapid molecular biology tests (direct rRT-PCR without extraction), although, in a hospital setting, these procedures may be performed only in addition to nasopharyngeal swabs to minimize the incidence of false-negative results. Conversely, the promising role of saliva in the diagnosis of SARS-CoV-2 infection is highlighted by the emergence of point-of-care technologies and, most important, point-of-need devices. Indeed, these devices can be directly used in workplaces, airports, schools, cinemas, and shopping centers. An example is the recently described Rapid Salivary Test, an antigen test based on the lateral flow assay, which detects the presence of the virus by identifying the spike protein in the saliva within a few minutes.

Indexed as

COVID-19COVID-19 TestingHumansReal-Time Polymerase Chain ReactionRNA, ViralSalivaSARS-CoV-2RNA, ViralcoronavirusCOVID-19point-of-care testingsalivaSARS-CoV-2Severe acute respiratory syndrome-related coronavirus

Identifiers

PMID33131360
PMCPMC7604673
OpenAlexW3097196035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.